Exercise performance and recovery is the main area connected here, and any felt benefit should be read together with the human evidence base.
Some human supplement-context evidence is present and directly informs the score.
Representative tier calculated from paper evidence that passed the collection audit.
The representative ingredient tier is calculated from these target-level evidence groups.
10 new papers were added in this period. No new risk signal was identified.
Standalone side-effect signals and combination cautions are listed separately.
The group showed a positive signal, but individual contributions are hard to isolate. Not a stack recommendation.
Paper IDs and full lists are private. Only study types and summaries are shown.
More research is needed to determine the effects of beta-alanine on strength, endurance performance beyond 25 min in duration, and other health-related benefits associated with carnosine.
The theoretical rationale and potential ergogenic value of β-ALA supplementation with or without creatine monohydrate is overviewed as well as future research recommendations are provided.
It is indicated for the first time, that beta-alanine supplementation is effective in increasing the muscle carnosine content in healthy elderly subjects, with subsequent improvement in their exercise capacity.
Chronic BA and SB supplementation alone equally enhanced high-intensity intermittent upper-body performance in well-trained athletes.
Ingesting the SUP before exercise significantly improved agility choice reaction performance and lower body muscular endurance, while increasing perceived energy and reducing subjective fatigue, suggest that the SUP may delay fatigue during strenuous exercise.
βA supplementation for 28 days enhanced sub-maximal endurance performance by delaying OBLA, however, βA supplemented individuals had a reduced aerobic capacity as evidenced by the decrease in VO2max values post supplementation.